About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us
 

About Us: Contact Us

 
 

7/7/2010 - Daxor Announces that Rush University Medical Center of Chicago, IL Acquires BVA-100 Blood Volume Analyzer

  

5/27/2010 - Daxor Announces Publication of Review Article on Use of Blood Volume Analysis to Guide Ultrafiltration in the Management of Congestive Heart Failure

  

5/10/2010 - Daxor Corporation Announces First Quarter 2010 Earnings and Payment of a Dividend

  
 

______________________

 
     
  DAXOR Corporation Newsletter; Issue 1, March 2010  
  2009 Form 10-K  
  2009 Second Quarter Earnings  
  September 2009 10-Q  
  2009 Proxy Statement  
  2008 Annual Report  
 
Corporate Headquarters DAXOR Corporation
Empire State Building
350 Fifth Ave., Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806
E-mail: info@daxor.com
Customer Support Office: 888-774-3268
8:00 a.m. to 5:00 p.m., M-F
Technical Support Don Betts
Office: 888-774-3268
Mobile: 501-277-9298
E-mail: dbetts@daxor.com
By Department  

Administration

Stephen Feldschuh
Office: 212-330-8515
Mobile: 917-553-8604
E-mail: stephen@daxor.com

Accounting

David Frankel
Office: 212-330-8504
E-mail: dfrankel@daxor.com

Human Resources

Diane Meegan
Office: 212-330-8512
E-mail: dmeegan@daxor.com

Investor Relations

Diane Meegan
Office: 212-330-8512
E-mail: dmeegan@daxor.com

Quality Assurance

Deanna O'Brien
Office: 865-425-0555
E-mail: dobrien@daxor.com

Clinical  Support

Dr. Joseph Feldschuh, M.D.
Chief Scientific Officer
Office: 212-330-8500
E-mail: jfeldschuh@daxor.com

Sales

To request BVA-100 information or to receive a revenue and cost analysis specific to your area, please call
1-888-774-3268
Menu Options

DAXOR Home Page

Mission Statement

Privacy Statement

Company Management

Careers

Contact Us

 

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2010 DAXOR Corporation. All Rights Reserved.